Skip to main content
SpringerLink
Log in

Antivirals/raltegravir interaction

Serum transaminases elevated (first report for interaction): case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Cattaneo D, et al. Suspected pharmacokinetic interaction between raltegravir and the 3D regimen of ombitasvir, dasabuvir and paritaprevir/ritonavir in an HIV-HCV liver transplant recipient. European Journal of Clinical Pharmacology 72: 365-367, No. 3, Mar 2016. Available from: URL: http://doi.org/10.1007/s00228-015-1936-6 - Italy

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antivirals/raltegravir interaction. Reactions Weekly 1593, 29 (2016). https://doi.org/10.1007/s40278-016-15672-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-016-15672-4

Search

Navigation